Additionally, APP interacted with Amyloid-Beta Precursor Protein Binding Protein 2 (APPBP2), which is involved in non-small cell lung cancer (NSCLC), a type of cancer accountable for ~ 80% of all lung carcinoma patients [33]. Here, APP is linked to non-small cell lung carcinoma.